We applied reverse two-sample MR (as described above) using GDF15 plasma levels as the outcome variable to assess associations with BMI, WHR, glucose, diabetes, HDL cholesterol, and eBMD as the MR exposures. The gene discussed is GDF15; the disease is diabetes mellitus.